SN hyperechogenicity has also been identified in individuals carrying mutations of PD genes (SNCA, PRKN, PINK1, DJ-1, LRRK2), both in PD patients exhibiting clinical symptoms and in asymptomatic individuals [9,10,11]. This evidence concerns the gene LRRK2 and Parkinson disease.